Walmart’s Report More Important Than Nvidia’s?... And Apple’s Cheaper AI IPhone 2/19/25
CNBC's "Fast Money"
Eli Lilly's Rally: Sustaining Gains or Taking Profits?
This chapter delves into Eli Lilly's impressive share price rise attributed to strong earnings and updates on a new weight loss drug. It explores whether this momentum can continue amid market volatility and examines competition from Novo Nordisk and potential industry tariffs.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
